Home » Topics » BioWorld Science

BioWorld Science
RSS

High-throughput proteomics identifies biomarkers of both rheumatoid arthritis and SLE

June 9, 2022

Cilagicin, next-generation antibiotic with activity against MDR isolates

June 9, 2022

Novel polyphenol derivative as potent DYRK1A inhibitor for the treatment of MS

June 9, 2022

Platelet-activating factor receptor antagonists discovered at Boehringer Ingelheim

June 9, 2022

Ningbo Combireg Pharmaceutical Technology presents deuterated anticancer compounds

June 9, 2022

ATP spreads inflammation by activating neural pathway and enhancing IL-6 amplifier

June 9, 2022

French researchers patent gold complexes and their use as antioxidants

June 9, 2022

CURACLE and collaborators patent carbazole derivative angiogenesis inhibitors

June 9, 2022

Humanwell Healthcare discloses LPAR1 antagonists

June 9, 2022

WNT plays dual role in melanoma spread to lung

June 8, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...